Results 21 to 30 of about 67,308 (301)
Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy
Bagcilar Medical Bulletin, 2016 Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the ...
Lebriz Uslu Besli, Ilhami Uslu
doaj +1 more source
Radiation Protection and Environment, 2020 Nonconjugated conductive polymers have unique characteristics for providing protection against nuclear radiation including radioactive iodine (carcinogenic) which remains in vapor phase at and above room temperature and is difficult to contain.
Mrinal Thakur
doaj +1 more source
Hürthle cell carcinoma: current perspectives. [PDF]
, 2016 Hürthle cell carcinoma (HCC) can present either as a minimally invasive or as a widely invasive tumor. HCC generally has a more aggressive clinical behavior compared with the other differentiated thyroid cancers, and it is associated with a higher rate ...
Ahmadi, Sara +3 more
core +1 more source
Treatment of Hyperthyroidism by Radioactive Iodine
Journal of the Royal College of Physicians of London, 1992 link_to_subscribed_fulltext
Hedley, AJ +7 more
openaire +2 more sources
World Journal of Nuclear Medicine, 2016 The influence of antithyroid drugs (ATDs) on the therapeutic efficacy of radioactive iodine in hyperthyroidism is still controversial. The aim of this study was to evaluate the effect of ATD discontinuation to the therapeutic efficacy of I-131 in ...
A. Hussein Sundawa Kartamihardja +1 more
doaj +1 more source
BMC Endocrine Disorders, 2021 Background The main purpose is to investigate the effect of LiCO3 as an add-on therapy with radioactive iodine in increasing the cure and decreasing the T4 level compared to radioactive iodine alone. The primary outcome is the cure rate as defined by the
Mohamed Abd-ElGawad +7 more
doaj +1 more source
Frontiers in Immunology, 2022 Differentiated thyroid cancer is the most frequently diagnosed endocrine tumor. While differentiated thyroid cancers often respond to initial treatment, little is known about the differences in circulating immune cells amongst patients who respond ...
Zhi-Yong Shi +23 more
doaj +1 more source
ENDOCRINE TUMOURS: Imaging in the follow up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach [PDF]
, 2016 The clinical and epidemiological profiles of differentiated thyroid cancers (DTCs) have changed in the last three decades. Today's DTCs are more likely to be small, localized, asymptomatic papillary forms.
Deandreis, Désirée +3 more
core +1 more source
A role for the small GTPases RAC1 and RAC1b in the modulation of NIS expression: potentiation of therapy with radioactive iodine in differentiated thyroid carcinoma [PDF]
, 2019 Introduction or Background: The Sodium Iodide Symporter (NIS) is responsible for active transport of iodide into thyroid follicular cells. The retention of its functional expression in most of the well-differentiated thyroid carcinomas (DTCs) enables ...
Bugalho, Maria J. +5 more
core +1 more source
Balkan Medical Journal, 2018 Background: Thyroid cancer is the most common endocrine cancer, with an increasing incidence around the world in the last three decades. The increased risk of secondary cancer is associated with a genetic predisposition or radioactive iodine used in the ...
Mahmut Büyükşimşek +4 more
doaj +1 more source